Public Company Healthcare

DePuy Synthes

Raynham, Massachusetts, United States

DePuy Synthes is Johnson & Johnson MedTech’s orthopaedics business, providing orthopaedic and related surgical solutions, including implants and instruments across orthopaedics and surgical specialties (such as Mitek Sports Medicine).

Focus Areas
Orthopaedic implants, Surgical instruments, Surgical solutions

Tracked deals

4

4 tracked deals across 2015-2026.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Buyout

4 buyout

DePuy Synthes Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for DePuy Synthes. 2 2022 ~2 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • DePuy Synthes Acquires Expanding Innovations, Inc.
    July 17, 2026
    Buyer
    DePuy Synthes
    Target
    Expanding Innovations, Inc.
    Industry
    Medical Devices
    Location
    California, United States
    Type
    Buyout

    DePuy Synthes, the orthopedics division of Johnson & Johnson MedTech, acquired Expanding Innovations, Inc., a commercial-stage medical technology company focused on expandable interbody cage systems for spine surgery. The acquisition adds proprietary non-screw-based expandable cage technology to strengthen DePuy Synthes’ spine implant portfolio in the lumbar fusion market.

  • Johnson & Johnson Completes Acquisition of Abiomed
    December 22, 2022
    Buyer
    Johnson & Johnson, Athos Merger Sub, Inc. (a wholly-owned subsidiary of Johnson & Johnson)
    Target
    Abiomed, Inc.
    Industry
    Medical Devices
    Location
    Massachusetts, United States
    Type
    Buyout

    Johnson & Johnson completed its acquisition of Abiomed through a tender offer and subsequent merger, for an upfront payment of $380.00 per share in cash (enterprise value ~ $16.6 billion), plus a non-tradeable contingent value right (CVR) up to $35.00 per share based on milestones. Abiomed will operate as a standalone business within Johnson & Johnson’s MedTech segment.

  • DePuy Synthes (Johnson & Johnson) Acquires CrossRoads Extremity Systems from HealthpointCapital
    February 10, 2022
    Buyer
    DePuy Synthes (Johnson & Johnson)
    Target
    CrossRoads Extremity Systems
    Seller
    HealthpointCapital Management LLC, MB Venture Partners
    Industry
    Medical Devices
    Location
    Tennessee, United States
    Type
    Buyout

    DePuy Synthes, the orthopaedics business of Johnson & Johnson, has acquired CrossRoads Extremity Systems, a Memphis-based designer and manufacturer of procedure-specific implants and instruments for foot and ankle surgery. The seller was HealthpointCapital (with long-time investor MB Venture Partners involved); HealthpointCapital had acquired a majority stake in CrossRoads in May 2019 and executed product and commercial expansion before the sale.

  • DePuy Synthes Companies Acquires Olive Medical Corporation
    February 10, 2015
    Buyer
    DePuy Synthes Companies
    Target
    Olive Medical Corporation
    Industry
    Medical Devices
    Location
    Utah, United States
    Type
    Buyout

    DePuy Synthes Companies has acquired Olive Medical Corporation, a Utah-based maker of high-definition visualization systems for minimally invasive surgery. The acquisition (financial terms undisclosed) adds arthroscopic visualization technology to DePuy Synthes' Mitek Sports Medicine portfolio and expands access to Olive Medical's solutions through DePuy Synthes' global distribution network.

Related Acquisition Pages

Medical Devices Buyers & Acquisitions 4 tracked deals by DePuy Synthes. Acquisitions in California 1 tracked deal by DePuy Synthes. Acquisitions in Massachusetts 1 tracked deal by DePuy Synthes. Acquisitions in Tennessee 1 tracked deal by DePuy Synthes. Acquisitions in Utah 1 tracked deal by DePuy Synthes.

Selling a company? Get in front of buyers like DePuy Synthes

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →